Search Results - Richman SP
- Showing 1 - 1 results of 1
-
1
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma by Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N
Published in Journal of Hepatocellular Carcinoma (2018-01-01)Get full text
Article
